AU2001295999A1 - Nateglinide-containing preparations - Google Patents

Nateglinide-containing preparations

Info

Publication number
AU2001295999A1
AU2001295999A1 AU2001295999A AU9599901A AU2001295999A1 AU 2001295999 A1 AU2001295999 A1 AU 2001295999A1 AU 2001295999 A AU2001295999 A AU 2001295999A AU 9599901 A AU9599901 A AU 9599901A AU 2001295999 A1 AU2001295999 A1 AU 2001295999A1
Authority
AU
Australia
Prior art keywords
nateglinide
containing preparations
antidiabetic
immediate
amorphous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295999A
Inventor
Chisato Makino
Nobutaka Ninomiya
Akira Yabuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2001295999A1 publication Critical patent/AU2001295999A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention discloses, as a immediate-release preparation useful as an antidiabetic, a nateglinide-containing preparation comprising nateglinide as an active ingredient wherein the nateglinide is amorphous. <IMAGE>
AU2001295999A 2000-10-24 2001-10-23 Nateglinide-containing preparations Abandoned AU2001295999A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000324373 2000-10-24
JP2000-324373 2000-10-24
PCT/JP2001/009291 WO2002034254A1 (en) 2000-10-24 2001-10-23 Nateglinide-containing preparations

Publications (1)

Publication Number Publication Date
AU2001295999A1 true AU2001295999A1 (en) 2002-05-06

Family

ID=18801918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295999A Abandoned AU2001295999A1 (en) 2000-10-24 2001-10-23 Nateglinide-containing preparations

Country Status (17)

Country Link
US (2) US7605180B2 (en)
EP (1) EP1334720B1 (en)
JP (3) JP4501054B2 (en)
KR (1) KR100869039B1 (en)
CN (1) CN100352432C (en)
AT (1) ATE406885T1 (en)
AU (1) AU2001295999A1 (en)
BR (1) BR0114896A (en)
CA (1) CA2426263C (en)
DE (1) DE60135674D1 (en)
DK (1) DK1334720T3 (en)
ES (1) ES2307653T3 (en)
MX (1) MXPA03003685A (en)
PT (1) PT1334720E (en)
RU (1) RU2271805C2 (en)
TW (1) TWI283573B (en)
WO (1) WO2002034254A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2305977T3 (en) * 1999-12-28 2008-11-01 Ajinomoto Co., Inc. ANTIDIABETIC PREPARATION FOR ORAL ADMINISTRATION.
SK14922002A3 (en) * 2000-03-17 2003-04-01 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
DK1334962T3 (en) * 2000-10-18 2007-12-10 Ajinomoto Kk Methods for preparing acylphenylalanine
MXPA03003484A (en) * 2000-10-18 2003-07-14 Ajinomoto Kk Process for producing nateglinide crystal.
JP4225057B2 (en) * 2000-10-24 2009-02-18 味の素株式会社 Method for producing nateglinide type B crystal
EP1334720B1 (en) * 2000-10-24 2008-09-03 Ajinomoto Co., Inc. Nateglinide-containing preparations
SI1334721T1 (en) * 2000-10-24 2009-08-31 Ajinomoto Kk Nateglinide-containing hydrophilic drug preparations
JP4833464B2 (en) * 2001-11-28 2011-12-07 大正製薬株式会社 Method for producing poorly soluble drug-containing solid preparation
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
JP4505859B2 (en) * 2003-08-08 2010-07-21 味の素株式会社 Nateglinide-containing preparation
WO2005020979A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions of nateglinide
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
KR20120064735A (en) * 2004-04-01 2012-06-19 아지노모토 가부시키가이샤 Nateglinide-containing preparation
KR20130018956A (en) * 2004-08-10 2013-02-25 아지노모토 가부시키가이샤 Nateglinide-containing preparation reduced in bitterness
JP4974057B2 (en) * 2005-01-31 2012-07-11 味の素株式会社 A pharmaceutical composition for improving or treating impaired glucose tolerance, borderline diabetes, insulin resistance and hyperinsulinemia, comprising a hypoglycemic agent
DE102005047561A1 (en) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
SI2140867T2 (en) 2007-03-29 2023-10-30 Daiichi Sankyo Company, Limited Pharmaceutical composition
TR200801178A2 (en) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Oral tablet compositions containing nateglinide and surfactant-ph regulating system
CN101590063A (en) * 2008-05-26 2009-12-02 中国科学院上海生命科学研究院 The application of tanshinone in the medicine of preparation treatment obesity and insulin resistant
ES2601884T3 (en) 2010-03-19 2017-02-16 Daiichi Sankyo Company, Limited Procedure to improve the dissolution capacity of an anticoagulant
US9150499B2 (en) 2010-06-14 2015-10-06 Cipla Limited Process for the preparation of nateglinide
CA2844604C (en) 2011-08-10 2017-07-18 Daiichi Sankyo Company, Limited Pharmaceutical composition containing ethanediamide derivatives
CN102813636B (en) * 2012-08-28 2014-04-16 西南药业股份有限公司 Nateglinide tablet and its preparation method
MX370853B (en) * 2013-07-22 2020-01-08 Sandoz Ag Formulations containing amorphous dapagliflozin.
JP6647902B2 (en) * 2015-10-30 2020-02-14 株式会社ファンケル Sustained release granules
KR20240025990A (en) * 2022-08-19 2024-02-27 주식회사 스카이테라퓨틱스 Amorphous sunitinib, preparation method thereof, and pharmaceutical composition containing amorphous sunitinib

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
FR2525108B1 (en) * 1982-04-19 1989-05-12 Elan Corp Ltd HIGH-SOLUBILITY MEDICINES AND PROCESS FOR OBTAINING THEM
JPH0249720A (en) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp Slightly soluble drug composition
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
JPH0415221A (en) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd Preparation of polycarbonate
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
ATE149483T1 (en) * 1991-07-30 1997-03-15 Ajinomoto Kk CRYSTALS OF N-(TRANS-4- ISOPROPYLCYCLOHEXYLCARBONYL)-D-PHENYLALANINE AND METHOD FOR THE PRODUCTION THEREOF
CA2271865C (en) * 1996-11-15 2003-10-14 Ajinomoto Co., Inc. Tablet composition
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
EP1049459B1 (en) * 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
ES2305977T3 (en) * 1999-12-28 2008-11-01 Ajinomoto Co., Inc. ANTIDIABETIC PREPARATION FOR ORAL ADMINISTRATION.
SK14922002A3 (en) * 2000-03-17 2003-04-01 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
DK1334962T3 (en) * 2000-10-18 2007-12-10 Ajinomoto Kk Methods for preparing acylphenylalanine
MXPA03003484A (en) * 2000-10-18 2003-07-14 Ajinomoto Kk Process for producing nateglinide crystal.
SI1334721T1 (en) * 2000-10-24 2009-08-31 Ajinomoto Kk Nateglinide-containing hydrophilic drug preparations
EP1334720B1 (en) * 2000-10-24 2008-09-03 Ajinomoto Co., Inc. Nateglinide-containing preparations
JP4225057B2 (en) * 2000-10-24 2009-02-18 味の素株式会社 Method for producing nateglinide type B crystal
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
JP4505859B2 (en) * 2003-08-08 2010-07-21 味の素株式会社 Nateglinide-containing preparation

Also Published As

Publication number Publication date
RU2271805C2 (en) 2006-03-20
KR100869039B1 (en) 2008-11-17
KR20030042027A (en) 2003-05-27
JP4501054B2 (en) 2010-07-14
JP5610165B2 (en) 2014-10-22
ATE406885T1 (en) 2008-09-15
US7605180B2 (en) 2009-10-20
ES2307653T3 (en) 2008-12-01
BR0114896A (en) 2003-08-12
MXPA03003685A (en) 2004-01-26
US20090203791A1 (en) 2009-08-13
EP1334720B1 (en) 2008-09-03
EP1334720A1 (en) 2003-08-13
JP2013028636A (en) 2013-02-07
JP2010100654A (en) 2010-05-06
CA2426263C (en) 2010-05-25
TWI283573B (en) 2007-07-11
PT1334720E (en) 2008-09-30
DK1334720T3 (en) 2009-01-19
WO2002034254A1 (en) 2002-05-02
JPWO2002034254A1 (en) 2004-08-26
CN1482903A (en) 2004-03-17
CN100352432C (en) 2007-12-05
DE60135674D1 (en) 2008-10-16
US20040014815A1 (en) 2004-01-22
EP1334720A4 (en) 2004-02-04
CA2426263A1 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
AU2001295999A1 (en) Nateglinide-containing preparations
AU2002305578A1 (en) Applanation tonometer
AU2001279972A1 (en) Pesticidal formulations
AU2001230477A1 (en) Active aid for a handheld camera
AU2001269844A1 (en) Self-standing, hand held implements
USD469180S1 (en) Elongated applicator handle having a distributor at both ends
USD462616S1 (en) Bottle
USD456051S1 (en) Exercise device
AU2002225025A1 (en) Agrochemical formulations
USD454308S1 (en) Bottle
USD488863S1 (en) Containers for components of medical devices
USD451971S1 (en) Exercise device
USD449424S1 (en) Horseshoe shaped novelty hat
AU1303099A (en) Herbicidal furanyl- and thienyloxyazines
USD457990S1 (en) Animal toy ring
AUPR836201A0 (en) Agricultural implements
USD447415S1 (en) Trigger sprayer
EP1018336A4 (en) Carcinostatics
USD462412S1 (en) Duck figure
USD459359S1 (en) Industrial mouse keypad
AU2001262282A1 (en) 3-(4,5-dihydroisoxazole-5-yl)benzoylcyclohexenones and the use thereof as herbicides
AU2001289902A1 (en) Novel herbicides
EP0970697A4 (en) Cervical maturing agent
USD470741S1 (en) Knob
AU2362401A (en) N-phenylcarbamates having a microbicide, insecticide and acaricide effect